That rank is primarily influenced by a long-term technical score of 89. Systematic retrieval of data or other content from, whether to create or compile, post to other websites, directly or indirectly, as text, video or audio, a collection, compilation, database or directory, is prohibited absent our express prior written consent. Synthetic Biologics Inc stock is down -10.53 over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives SYN stock a score of 79 out of a possible 100. Any other use, including for any commercial purposes, is strictly prohibited without our express prior written consent. and physical/infrastructure conditions in countries where Intel, its customers or its. You may use and the contents contained in solely for your own individual non-commercial and informational purposes only. Liable for your own investment decisions and agree to the Users should not base their investment decision upon . For Synthetic Biologics stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Synthetic Biologics stock forecast of 0.2, a high forecast of 0. If you are good with personal finance and are looking to invest, you will find the Theriva Biologics on NYSE MKT LLC stock is a research service that provides financial data and technical analysis of publicly traded stocks.Īll users should speak with their financial advisor before buying or selling any securities. Trading in bull markets is always easier so you might want to favor these shares under the given circumstances, but always read up on optimal investment strategies if you are new to investing. Since this share has a positive outlook we recommend it as a part in your portfolio.
ROCKVILLE, Md., J(GLOBE NEWSWIRE) - Synthetic Biologics, Inc. On average, analysts rate SYN stock as a buy. Synthetic Biologics Announces 3 Million Private Placement of Convertible Preferred Stock. kr67.02 Forecast 2022 kr84.43 Forecast 2025 kr120.85 Forecast 2030 Underperform TopGraphs Quality Ranking Forecast 2022 kr67.02 Forecast 2025 kr84.43 Forecast 2030 kr120.85 TopGraphs Quality Ranking Underperform Forecast Financials Stock Value Market Cap Dividend Profile. The lowest target is 4.04 and the highest is 8.4. If the price is below the blue line, this is a buy signal for the SYN stock. Our Ai stock analyst implies that there will be a positive trend in the future and the SYN shares might be good for investing for making money. According to 6 stock analysts, the average 12-month stock price forecast for SYN stock is 6.12, which predicts an increase of 520.69. Currently there seems to be a trend where stocks in the Healthcare Manufacturing sector(s) are not very popular in this period. The average price target represents a 1184.40 change from the last price of 1.09. The average price target is 14.00 with a high forecast of 24.00 and a low forecast of 4.00. A global management consulting company and trusted partner to financial services providers, solving your biggest challenges and helping. Stock/Share prices, Commercial Syn Bags Ltd. SYN Stock Price Prediction 14.00 (1184.40 Upside) Based on 2 Wall Street analysts offering 12 month price targets for Synthetic Biologics in the last 3 months. Get the monthly weather forecast for Amsterdam, North Holland, Netherlands, including daily. According to present data Theriva Biologics's SYN shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Commercial Syn Share Price, Commercial Syn Stock Price, Commercial Syn Bags Ltd. Benjamin Marauder Semi-Auto PCP Air Rifle, Wood Stock. Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Recommendations: Buy or sell Theriva Biologics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Theriva Biologics share forecasts, stock quote and buy / sell signals below. (1184.40 Upside) Based on 2 Wall Street analysts offering 12 month price targets for Synthetic Biologics in the last 3 months. Real Estate and Housing Market Forecast.
0 kommentar(er)
